The Group's mission is to help improve the quality of life by offering pharmaceutical products and services designed against the diseases that mainly influence human health, especially in the cardiovascular and immuno-oncological areas.

At the same time, by fulfilling its mission, Italfarmaco aims to contribute to the cultural, technological and economic progress of the countries in which it operates. The company's strategy is oriented towards a major research effort in its core therapeutic areas, and is aimed at achieving gradual international expansion.